Welcome to our dedicated page for Zepp Health Corporation news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health Corporation stock.
Zepp Health Corporation (NYSE: ZEPP) drives innovation at the intersection of wearable technology and digital health solutions. This news hub provides investors and industry professionals with essential updates on the company's advancements in smart health monitoring, strategic partnerships, and market leadership.
Access official press releases covering earnings reports, product launches (including Amazfit devices), technology collaborations, and operational developments. Our curated collection offers timely insights into ZEPP's proprietary health platforms, AI-driven innovations, and global expansion efforts within the $200B+ wearable technology sector.
Key updates include financial performance disclosures, R&D breakthroughs in biometric sensors, strategic alliances with health tech leaders, and regulatory milestones. The resource serves both casual observers tracking consumer wearable trends and professional analysts monitoring the competitive digital health landscape.
Bookmark this page for streamlined access to verified information about ZEPP's initiatives in personal wellness technology, without promotional bias or speculative commentary. Refresh regularly to stay current with developments impacting the company's position in global markets.
Zepp Health Corporation (NYSE: ZEPP) filed its annual report on Form 20-F for the fiscal year ending December 31, 2022, with the U.S. Securities and Exchange Commission. The report details the company’s performance as a leader in cloud-based healthcare services and smart wearable technology. The 2022 filing highlights that Zepp Health shipped 20 million units in smart health devices, reinforcing its position as a global leader in the sector. Shareholders can request free hardcopies of the report by contacting the company directly.
Founded in 2013, Zepp Health was known as Huami Corp. until its name change on February 25, 2021. The company continues to innovate with AI chips and biometric sensors aimed at enhancing health technology.
Zepp Health Corporation (NYSE: ZEPP) reported Q4 2022 revenues of RMB1.1 billion (US$155.4 million), a 35.5% decrease from Q4 2021, primarily due to a 65.5% drop in Mi Band sales. The company recorded a net loss of RMB75.5 million, contrasting with a net income of RMB36.3 million a year earlier. However, self-branded products saw a 28.5% quarter-over-quarter revenue growth and accounted for 77.4% of total revenues. Gross margin improved to 20.7%, driven by optimized product offerings. Looking ahead, Zepp anticipates Q1 2023 revenues between RMB0.60 billion and RMB0.75 billion, reflecting market uncertainties and sales conditions.
FAQ
What is the current stock price of Zepp Health Corporation (ZEPP)?
What is the market cap of Zepp Health Corporation (ZEPP)?
